Archive for March, 2008
Ten years ago this month the lives of millions of men and women were changed almost overnight by the advent of a little blue pill — the first oral treatment for impotence.
Viagra, developed by accident by scientists at Pfizer Laboratories, was first approved for use by the US Food and Drug Administration on March 27, [...]
March 27th, 2008 | Posted in Anti-impotence drugs, Drugs and Medications, Pfizer, Sex pills | No Comments
Patients who receive free drug samples from their doctors end up having significantly higher out-of-pocket costs for their prescription drugs than people who don’t receive free samples, a new study finds.
In fact, patients who received free samples spent about $166 in out-of-pocket costs on prescription drugs in the six months before receiving the samples, $244 [...]
March 25th, 2008 | Posted in Drugs and Medications, Research | No Comments
In the latest research to cast a shadow on the safety of a popular bone-strengthening medication, researchers report that long-term use of Fosamax is associated with unusual fractures of the thigh bone.
The fractures were low-energy fractures, meaning that they all occurred from a fall from standing height or less, and the bone cracks were in [...]
March 21st, 2008 | Posted in Bone-strengthening medications, Drugs and Medications, Research | No Comments
The European Commission has referred GlaxoSmithKline Plc’s breast cancer treatment Tyverb back for a fresh assessment by drugs regulators following new data from Europe’s biggest pharmaceuticals company.
Glaxo said on Tuesday that Tyverb, which is already on sale in the United States under the name Tykerb, had been referred back to the EU’s Committee for Medicinal [...]
March 18th, 2008 | Posted in Cancer drugs, Drugs and Medications, GlaxoSmithCline | No Comments
U.S. health officials have ordered all imports of the blood thinner heparin, and its raw ingredient, stopped at the border for testing to detect a contaminant linked to 19 deaths.
The Food and Drug Administration announced the move Friday, the latest step in its widening investigation of hundreds of allergic-type reactions linked to Baxter International’s heparin [...]
March 16th, 2008 | Posted in Blooding-thinning drugs, Drugs and Medications, Warnings! | No Comments
Drug maker Amgen Inc. said Friday it expanded black box warnings about risks of death and tumor growth of its blockbuster anemia drugs.
The warnings approved by the Food and Drug Administration state that the company’s drugs increased death and accelerated tumor growth in patients with early stage breast cancer and cervical cancer. Earlier labeling warned [...]
March 12th, 2008 | Posted in Drug makers, Drugs and Medications, Research, Warnings! | No Comments
Spectrum Pharmaceuticals, Inc. today announced that it has received marketing approval from the U.S. Food and Drug Administration (FDA) for Levoleucovorin for Injection. It is indicated after high-dose methotrexate therapy in patients with osteosarcoma, and to diminish the toxicity and counteract the effects of impaired methotrexate elimination or inadvertent overdose of folic acid antagonists. LEVOleucovorin [...]
March 9th, 2008 | Posted in Cancer drugs, Drugs and Medications, New drugs | No Comments
AstraZeneca Plc is stopping a clinical trial of Recentin as a treatment for lung cancer after a mid-stage study failed to meet its main goal, although trials in colorectal cancer will move ahead.
The mixed news on Wednesday adds to the company’s patchy record on drug research, analysts said.
Recentin, which is given as a pill, is [...]
March 1st, 2008 | Posted in AstraZeneca, Drugs and Medications | No Comments
Canadian drug stores have begun stocking a new full-time version of an anti-impotence drug its makers say will allow men to be sexually “spontaneous,” day and night.
Cialis was originally designed to be taken on an “as needed” basis, with one dose lasting 24 to 36 hours, earning it the moniker “Le Weekend” when first approved [...]
March 1st, 2008 | Posted in Drugs and Medications, Eli Lilly, Sex pills, Sexual health | 1 Comment